The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

The anatomy of my decision to take a PAUSE and explore life outside the cancer center director’s office

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Shortly, I will step aside as director of the University of Iowa Holden Comprehensive Cancer Center, a role I have served in since 1998, i.e. a term roughly bookended by Y2K and COVID. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Byline
George J. Weiner, MD
Director, Holden Comprehensive Cancer Center, CE Block Chair of Cancer Research, University of Iowa
Table of Contents

YOU MAY BE INTERESTED IN

Conversation with The Cancer Letter

OHSU Knight Cancer Institute splits leadership role in two: (1) CEO and (2) center director
Eight NCI-designated centers believe the top job is too big for one person

A previous version of this story stated incorrectly that seven institutions split the role of director in two. The original list omitted Fox Chase Cancer Center. Read more.Slowly, over the past two decades, at least eight major cancer centers have changed their organizational structures, splitting the job of the cancer center director into two boxes on the org chart: (1) the chief executive, and (2) the scientist in charge of the NCI Cancer Center Support Grant.
By Paul Goldberg
Byline
George J. Weiner, MD
Director, Holden Comprehensive Cancer Center, CE Block Chair of Cancer Research, University of Iowa
Table of Contents

Login

Looking for IP Login?